2000
DOI: 10.1006/jmbi.2000.3892
|View full text |Cite
|
Sign up to set email alerts
|

Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIα by selective mutagenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
15
0

Year Published

2001
2001
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 36 publications
1
15
0
Order By: Relevance
“…In order to investigate further the unexplained increase in cell death induced by high concentrations of genistein in RINm5F cells, the cells were exposed to the drug in the presence of ciprofloxacin. This reagent does not interact with tyrosine kinases but, rather, it binds to DNA topoisomerase enzymes ( Elsea et al ., 1997 ; Hammonds et al ., 2000 ). Over periods up to 24 h, ciprofloxacin did not cause any direct loss of RINm5F cell viability (Figure 5) nor did it alter the extent of cell death induced by NaF (not shown).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In order to investigate further the unexplained increase in cell death induced by high concentrations of genistein in RINm5F cells, the cells were exposed to the drug in the presence of ciprofloxacin. This reagent does not interact with tyrosine kinases but, rather, it binds to DNA topoisomerase enzymes ( Elsea et al ., 1997 ; Hammonds et al ., 2000 ). Over periods up to 24 h, ciprofloxacin did not cause any direct loss of RINm5F cell viability (Figure 5) nor did it alter the extent of cell death induced by NaF (not shown).…”
Section: Resultsmentioning
confidence: 99%
“…Ciprofloxacin is a quinolone antibiotic that binds to mammalian DNA topoisomerase II at a site which overlaps the binding site for genistein ( Elsea et al ., 1997 ; Hammonds et al ., 2000 ). Binding of ciprofloxacin does not cause any loss of enzyme activity ( Elsea et al ., 1997 ; Hammonds et al ., 2000 ) whereas the interaction of genistein with topoisomerase II leads to loss of the DNA ligase activity of the enzyme.…”
Section: Discussionmentioning
confidence: 99%
“…Antibacterial fluoroquinolones are a class of antibacterial agents that are commonly used to treat human and animal infections. The treatment of bacterial infection inhibits bacterial DNA gyrase by a mechanism similar to that of certain antitumor drugs against mammalian topoisomerase II [17]. Some antibacterial fluoroquinolones, such as ciprofloxacin, ofloxacin and norfloxacin, also demonstrate a slight interaction with mammalian topoisomerase II, although these antibacterials are much more selective for bacterial DNA gyrase [18].…”
Section: Discussionmentioning
confidence: 99%
“…The treatment of bacterial infection inhibits bacterial DNA gyrase by a mechanism similar to that of certain antitumor drugs against mammalian topoisomerase II [17] . Some antibacterial fluoroquinolones, such as ciprofloxacin, ofloxacin and norfloxacin, also demonstrate a slight interaction with mammalian topoisomerase II, although these antibacterials are much more selective for bacterial DNA gyrase [18] .…”
Section: Wwwchinapharcom Shi Zy Et Almentioning
confidence: 99%
“…These findings provide evidence that QNT4 is a poisonous inhibitor for topoisomerase II [21] . QNT4 binds the reversible complex between DNA and topoisomerase II, preventing the dissociation of the DNA-topoisomerase II complex and thereby inducing DNA damage [22,23] . It has been reported that one of the key responses of fluoroquinolone-induced DNA damage is the expression of tumor suppressor protein p53, causing apoptosis of the treated cells [24,25] .…”
Section: Wwwchinapharcom Shi Zy Et Almentioning
confidence: 99%